Search results for "PATIENT"

showing 10 items of 5265 documents

Inhaled anesthesia in neurosurgery: Still a role?

2021

In patients undergoing craniotomy, general anesthesia should be addressed to warrant good hypnosis, immobility, and analgesia, to ensure systemic and cerebral physiological status and provide the best possible surgical field. Regarding craniotomies, it is unclear if there are substantial differences in providing general anesthesia using total intravenous anesthesia (TIVA) or balanced anesthesia (BA) accomplished using the third generation halogenates. New evidence highlighted that the last generation of halogenated agents has possible advantages compared with intravenous drugs: rapid induction, minimal absorption and metabolization, reproducible pharmacokinetic, faster recovery, cardioprote…

medicine.medical_specialtyHypnosisBalanced Anesthesiabusiness.industrymedicine.medical_treatmentHemodynamicsBrainAnesthesia GeneralNeurosurgical ProceduresThird generationAnesthesiology and Pain MedicineOpioidAnesthesiaAnesthesia Recovery PeriodmedicineHumansIn patientNeurosurgeryAnesthesia InhalationbusinessDesfluraneNeurophysiological MonitoringCraniotomymedicine.drugBest Practice & Research Clinical Anaesthesiology
researchProduct

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of …

2017

Abstract The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn’s disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases.

medicine.medical_specialtyIBDDiseaseGuidelineGuidelinesInflammatory bowel diseaseGastroenterologyBiological drugs03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineMedicalmedicineCorticosteroidCorticosteroidsHumansIn patient030212 general & internal medicineCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Hepatology; GastroenterologySocieties MedicalCrohn's diseaseSettore MED/12 - GastroenterologiaUlcerative colitiHepatologybusiness.industryImmunosuppressorsRemission InductionGastroenterologyInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesClinical PracticeCrohn's diseaseUlcerative colitisItalyImmunosuppressorCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Adrenal Cortex Hormones; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Italy; Remission Induction; Societies Medical030211 gastroenterology & hepatologybusinessSocietiesImmunosuppressive Agents
researchProduct

Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)

2017

medicine.medical_specialtyIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismBiochemistryOutcome (game theory)EndocrinologyInternal medicineGeneticsmedicineIn patientbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

MP-07.06

2006

medicine.medical_specialtyIleocecal valvemedicine.anatomical_structurebusiness.industryUrologyUrinary systemmedicineIn patientBowel functionbusinessContinent Urinary DiversionSurgeryUrology
researchProduct

Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis

2013

Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA) and a significant cause of morbidity and mortality. Usual interstitial pneumonia and nonspecific interstitial pneumonia seem to be the most frequent patterns in RA patients with ILD, although the proportion of patients with usual interstitial pneumonia is higher than among patients with other systemic rheumatic autoimmune diseases. RA patients with ILD most frequently present with chronic symptoms of cough and dyspnea when climbing stairs or walking uphill. A physical examination may reveal inhalatory crackles and a pulmonary function test demonstrates restrictive physiology, often with re…

medicine.medical_specialtyImmunologyArthritisLung biopsyGastroenterologyPulmonary function testingArthritis RheumatoidAntibodies Monoclonal Murine-DerivedPatient Education as TopicUsual interstitial pneumoniaInternal medicinemedicineHumansImmunology and AllergyAntibodies BlockingPneumonitisLeflunomideClinical Trials as TopicTumor Necrosis Factor-alphabusiness.industryInterstitial lung diseaseIsoxazolesmedicine.diseaserespiratory tract diseasesMethotrexateAntirheumatic AgentsRheumatoid arthritisImmunologyLung Diseases InterstitialRituximabbusinessLeflunomidemedicine.drugExpert Review of Clinical Immunology
researchProduct

Efficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Dupli…

2018

Abstract Introduction: FLT3-ITD mutations are among the most common molecular abnormalities in AML, occurring in ≈ 25% of pts. These driver mutations are associated with high leukemic burden and poor prognosis, eg, high risk of relapse, decreased response to salvage therapy, and shorter overall survival (OS). Pts with R/R FLT3-ITD AML have a worse prognosis and represent a population with high unmet medical need. Q is a once-daily, oral, highly potent and selective FLT3i shown in phase 2 trials to have promising single-agent antileukemic activity and a manageable safety profile. QuANTUM-R was the first global, phase 3, randomized controlled trial (NCT02039726) to show that an FLT3i prolonge…

medicine.medical_specialtyImmunologyPopulationSalvage therapyBiochemistrylaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicinemedicineIn patienteducationQuizartinibeducation.field_of_studybusiness.industryCell BiologyHematologyTransplantationchemistry030220 oncology & carcinogenesisRelapsed refractorybusiness030215 immunologyFlt3 itdBlood
researchProduct

Bilateral jaws involvement of Burkitt?s lymphoma in a pediatric patient

2021

A case of Burkitt’s lymphoma with bilateral jaws involvement in a 5-year-old boy is reported discussing the dentist’s role in the diagnosis and management of this disease. The initial clinical diagnosis established of maxillary swelling causing trismus was a dentoalveolar abscess. The incisional biopsy was performed and histopathological analysis, including immunohistochemistry, confirmed the Burkitt’s lymphoma. The patient underwent treatment and remains free of the disease for 36 months of follow-up. The occurrence of intraoral bilateral jaws involvement of Burkitt’s lymphoma in child is unusual and its accurate diagnosis avoids complications in the patient’s treatment. Key words:Burkitt’…

medicine.medical_specialtyIncisional biopsyOral Medicine and Pathologybusiness.industryCase Reportmedicine.diseaseTrismusLymphomaSurgeryPediatric patientimmune system diseasesMaxillary swellinghemic and lymphatic diseasesMaxillamedicineMAXILAmedicine.symptomAbscessbusinessGeneral DentistryBurkitt's lymphomaUNESCO:CIENCIAS MÉDICAS
researchProduct

Eight-point compass rose underlay technique in 72 consecutive elderly patients with large incisional hernia

2011

Summary Background Repair of incisional hernia (IH) in the elderly is a challenge for the surgeon. Primary closure is preferable but is not always possible because of high recurrence rates of IH repaired without a prosthesis and/or possible respiratory and cardiovascular complications due to extreme tension of the margins. We report our experience with underlay mesh placement in elderly patients with large IH. Methods A total of 72 patients from January 2003 to December 2009 underwent IH repair involving placement of an intraperitoneal Gore® DualMesh® prosthesis. The prosthesis was first anchored at eight points in a compass rose pattern using a Gore® suture passer and then firmly secured t…

medicine.medical_specialtyIncisional herniamedicine.medical_treatmentHigh-risk elderly patientAdhesion (medicine)lcsh:GeriatricsProsthesisePTFE meshTension-free techniqueAbdominal wallLarge ventral herniaSuture (anatomy)PneumoperitoneumePTFE mesh; High-risk elderly patients; Large ventral hernia; Suture passer; Tension-free techniquemedicineLaparoscopyhigh-risk elderly patientsSuture passermedicine.diagnostic_testbusiness.industrymedicine.diseaseSurgeryDissectionlcsh:RC952-954.6Settore MED/18 - Chirurgia Generalemedicine.anatomical_structureGeriatrics and Gerontologybusiness
researchProduct

Response to Letter Regarding Article, “Different Calculations of Ankle Brachial Index and Their Impact on Cardiovascular Risk Prediction”

2009

We thank Jaquinandi et al for their interest in our publication. We want to stress that the patient population of the AtheroGene study is not comparable with the patient populations reported in the articles from Lee et al and Kreitner et al, which included only patients with known advanced peripheral arterial disease.1,2 The AtheroGene study includes primarily patients with coronary artery disease, no patient had rest pain or peripheral ulcers and only 52 patients (6.3%) had intermittent claudication.3 In addition, …

medicine.medical_specialtyIndex (economics)business.industrymedicine.diseasePeripheralCoronary artery diseasePatient populationmedicine.anatomical_structurePhysiology (medical)medicinePhysical therapyAnkleCardiology and Cardiovascular MedicinebusinessRest (music)Circulation
researchProduct

Clinical Benefits of Early Triptan Therapy for Migraine

2004

The introduction of the triptans brought advances in achieving complete and sustained pain resolution in migraine patients, compared with non-migraine-specific treatments. However, sustained pain-free rates for triptans recorded in many clinical trials are still relatively low. This may be due to study participants being treated late into the attack, when pain is already moderate or severe. Studies with almotriptan have shown that efficacy is enhanced when treatment is given early in a migraine attack while pain is still mild, compared with later administration when pain intensity is greater. Developments in our understanding of migraine pathophysiology provide a rationale for this phenome…

medicine.medical_specialtyIndolesCentral sensitizationMigraine DisordersTriptans03 medical and health sciences0302 clinical medicinePatient satisfactionIntervention (counseling)AlmotriptanSecondary PreventionmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Intensive care medicineAnalgesicsClinical Trials as TopicEvidence-Based Medicinebusiness.industryDisease progressionGeneral Medicinemedicine.diseaseTryptaminesSerotonin Receptor AgonistsClinical trialTreatment OutcomeMigrainePatient SatisfactionAcute DiseaseDisease ProgressionPhysical therapyNeurology (clinical)businessAttitude to Health030217 neurology & neurosurgerymedicine.drugCephalalgia
researchProduct